About this trial
The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of the prototypes, including its features will focus on the feasibility, usefulness as well as the potential clinical value add in minimally invasive ICH treatment.
Eligibility criteria
Qualifiers
Patient ≥ 18 years old
Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Disqualifiers
Patient is < 18 years old
Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Trial design
Treatments tested in this trial
- DynaCT Multiphase
- DynaCT Sine Spin
Treatment groups
Sponsors and collaborators
Icahn School of Medicine at Mount Sinai
Lead sponsor
Siemens Corporation, Corporate Technology
Collaborator